Traders Are Already Fading The Biggest Biotech Move In Years

Two days after the biggest session of its life, Moderna is already giving some back, and roughly $6.8 million in put premium has hit the tape across Moderna and Merck. This digs into what the release actually contained, including no hazard ratio and no survival curve. The signal is the calendar. The Moderna puts expire weeks before the full data is presented at ESMO in late October, making them a fade of the move rather than a verdict on the science. The Merck put reaches past that release and past its third quarter call. Education, not a recommendation. 📊 tastylive: https://www.tastylive.com/ 📰 Get Tom's pre-market analysis every morning: https://www.tastylive.com/newsletters 📘 FREE Options Strategy Guide: https://tinyurl.com/bp9ms763 📱 Follow tastylive on X: https://x.com/tastyliveshow Chapters 00:00 Betting against the biggest move 00:56 What the two stocks did 01:26 What the release left out 02:06 The first bets on Moderna 02:53 Where those levels sit now 03:26 The calendar is the problem 03:57 A cleaner setup in Merck 04:53 Volatility trade versus information trade 05:37 Why the calendar is the signal #tastylive #moderna #merck #optionstrading #unusualoptionsactivity #biotech #optionsflow #putoptions #stockmarket #trading tastylive is a real financial network, producing hours of live programming every day. Follow along as our experts navigate the markets, provide actionable trading insights, and teach you how to trade. With over 120 original segments, and over 25 personalities, we'll help you take your trading to the next level, whether you are new to trading or a seasoned veteran. tastylive content is created, produced, and provided solely by tastylive, Inc. ("tastylive") and is for informational and educational purposes only. It is not, nor is it intended to be, trading or investment advice or a recommendation that any security, futures contract, digital asset, other product, transaction, or investment strategy is suitable for any person. Trading securities, futures products, and digital assets involve risk and may result in a loss greater than the original amount invested. Investment information provided may not be appropriate for all investors and is provided without respect to individual investor financial sophistication, financial situation, investing time horizon or risk tolerance. Options, futures, and futures options are not suitable for all investors. Prior to trading securities, options, futures, or futures options, please read all applicable risk disclosures, including, but not limited to, the Characteristics and Risks of Standardized Options Disclosure and the Futures and Exchange Traded Options Risk Disclosure Statement found at https://tastytrade.com/disclosures/. Past performance is not indicative of future results. Performance is not presented net of all commissions, fees, and expenses. Multi-leg option strategies incur higher transaction costs than single leg trades as they involve multiple commission charges. Examples provided are for illustrative, informational, and educational purposes only and are not intended to be reflective of results you can expect to achieve. Supporting documentation for any claims, including claims made on behalf of options programs), comparisons, statistics, or other technical data, if applicable, will be supplied upon request. tastylive, through its content, financial programming or otherwise, does not provide investment or financial advice or make investment recommendations. tastylive is not a licensed financial adviser, registered investment adviser, or a registered broker-dealer.